Shares of Callaway Golf (NYSE:ELY) have received a consensus recommendation of “Hold” from the seven ratings firms that are presently covering the stock, AmericanBankingNews.com reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating, two have issued a buy rating and one has issued a strong buy rating on the company. Callaway Golf Co (NYSE:ELY) shares after opening at $9.67 moved to $9.76 on last trade day and at the end of the day closed at $9.58. Company price to sales ratio in past twelve months was calculated as 0.87 and price to cash ratio as 19.88. Callaway Golf Co (NYSE:ELY) showed a positive weekly performance of 7.88%.
On March 15, 2014, John E. Toffolon, Jr. resigned from the Board of Directors of Cowen Group, Inc. (NASDAQ:COWN) for personal reasons, effective immediately. Mr. Toffolon also resigned as Chairman of the Company’s Audit Committee and as a member of the Company’s Compensation Committee. Cowen Group Inc. (NASDAQ:COWN) shares advanced 4.43% in last trading session and ended the day on $4.71. COWN return on equity ratio is recorded as -1.50% and its return on assets is -0.50%. Cowen Group Inc. (NASDAQ:COWN) yearly performance is 70.04%.
Basic Energy Services (NYSE:BAS) VP Brett J. Taylor sold 4,879 shares of the company’s stock on the open market in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $25.60, for a total value of $124,902.40. Following the completion of the sale, the vice president now directly owns 46,557 shares of the company’s stock, valued at approximately $1,191,859. Basic Energy Services, Inc. (NYSE:BAS) shares moved down -0.31% in last trading session and was closed at $25.39, while trading in range of $25.00 – $26.31. Basic Energy Services, Inc. (NYSE:BAS) year to date (YTD) performance is 60.90%.
Neuralstem, Inc. (NYSEMKT:CUR) announced that the final results from the Phase I safety trial using NSI-566 spinal cord stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease) were published in the peer-reviewed journal, “Annals of Neurology”. Neuralstem, Inc. (NYSEMKT:CUR) weekly performance is 28.06%. On last trading day company shares ended up $4.61. Neuralstem, Inc. (NYSEMKT:CUR) distance from 50-day simple moving average (SMA50) is 32.66%. Analysts mean target price for the company is $4.50.